LMR Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-60,000
Closed -$3.28M 1589
2025
Q3
$3.28M Hold
60,000
0.01% 612
2025
Q2
$3.19M Buy
60,000
+49,600
+477% +$2.52M 0.02% 559
2025
Q1
$450K Sell
10,400
-203,300
-95% -$10.3M ﹤0.01% 931
2024
Q4
$12M Buy
213,700
+36,500
+21% +$2.27M 0.1% 204
2024
Q3
$12.1M Buy
+177,200
New +$10M 0.1% 187
2024
Q2
Sell
-60,800
Closed -$4.2M 1163
2024
Q1
$4.2M Buy
60,800
+30,800
+103% +$1.95M 0.04% 376
2023
Q4
$2.22M Sell
30,000
-110,500
-79% -$7.24M 0.03% 450
2023
Q3
$9.58M Buy
+140,500
New +$11.9M 0.11% 192

Other funds holding EXAS

LMR Partners's EXAS Position: Q1 2026 in Review

LMR Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 881,340 shares — an estimated $89.5M sold.

LMR Partners first reported a position in EXAS in Q2 2017 and held it in 16 quarters. The position peaked at $89.5M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • LMR Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • LMR Partners sold 881,340 Exact Sciences shares in Q1 2026, an estimated $89.5M.
  • LMR Partners first reported a position in Exact Sciences in Q2 2017 and held it in 16 quarters.
  • LMR Partners's Exact Sciences position peaked at $89.5M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.